Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05229432 · ClinicalTrials.gov registry record

Study of Gastric Motility in Eosinophilic Gastritis

A clinical trial of Gastroparesis and Eosinophilic Gastritis, sponsored by Children's Hospital Medical Center, Cincinnati.

Recruiting
Registry status
30
Enrollment target
3
Study locations

NCT05229432 is a study of Gastroparesis and Eosinophilic Gastritis that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 30 participants, below the 301-participant average among 44 other Gastroparesis trials with a reported enrollment target (90% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05229432, a study of Gastroparesis and Eosinophilic Gastritis, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.

RECRUITING
Registry status
30 participants
Enrollment target
3
Study locations

Study Summary

Purpose: The study is a cross-sectional observational study designed to determine if eosinophilic gastritis (EG) results in gastric motility impairment. Hypothesis: Gastric dysfunction occurs in the natural history of EG but is underdiagnosed due, in part, to contraindications to the use of the standard meals used in gastric emptying studies.

Study Locations (3)

Illinois

  • Northwestern University - Chicago

Maryland

  • The National Institutes of Health - Bethesda

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-01-25
Est. Completion 2026-12-01

What the Registry Record Tells You About NCT05229432

The ClinicalTrials.gov registry entry for NCT05229432 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 301-participant average among 44 other Gastroparesis trials with a reported enrollment target (90% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Gastroparesis appearing as the primary indexed condition, and to 0 interventions.

NCT05229432 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Illinois, Maryland, Utah.

Frequently Asked Questions

What is clinical trial NCT05229432 about?

NCT05229432 is a clinical study titled "Study of Gastric Motility in Eosinophilic Gastritis". Purpose: The study is a cross-sectional observational study designed to determine if eosinophilic gastritis (EG) results in gastric motility impairment. Hypothesis: Gastric dysfunction occurs in the natural history of EG but is underdiagnosed due, in part, to contraindications to the use of the s...

What is the current status of trial NCT05229432?

This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2023-01-25. Estimated completion is 2026-12-01.

What conditions does trial NCT05229432 study?

This clinical trial studies the following conditions: Gastroparesis, Eosinophilic Gastritis, Gastric Motility Disorder.

Who is sponsoring clinical trial NCT05229432?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05229432 being conducted?

This trial has 3 study locations across Illinois, Maryland, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastroparesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.